Zobrazeno 1 - 10
of 16
pro vyhledávání: '"A. S. Robeva"'
Autor:
Raina S. Robeva, John R. Jungck
Publikováno v:
Axioms, Vol 12, Iss 3, p 280 (2023)
While Luria and Delbrück’s seminal work has found its way to some college biology textbooks, it is now largely absent from those in mathematics. This is a significant omission, and we consider it a missed opportunity to present a celebrated concep
Externí odkaz:
https://doaj.org/article/66c3bb9d03c441c4919e9be31c514d87
Autor:
Jungck, Raina S. Robeva, John R.
Publikováno v:
Axioms; Volume 12; Issue 3; Pages: 280
While Luria and Delbrück’s seminal work has found its way to some college biology textbooks, it is now largely absent from those in mathematics. This is a significant omission, and we consider it a missed opportunity to present a celebrated concep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::0970822cdaf6244427a7c03644310fc1
Publikováno v:
The Journal of Comparative Neurology. 401:163-186
The A2A adenosine receptor (A2A-AR) transcript and radioligand binding sites have a distinct distribution in rat brain, restricted primarily to the striatum, nucleus accumbens and olfactory tubercles. We describe here the use of purified recombinant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba24f121a9141ca99ef7dbd7f8249c8e
https://doi.org/10.1002/(sici)1096-9861(19981116)401:2<163::aid-cne2>3.0.co
https://doi.org/10.1002/(sici)1096-9861(19981116)401:2<163::aid-cne2>3.0.co
Autor:
Joel Linden, Zhenhai Gao, Robin L. Woodard, Anna S. Robeva, Samita Bhattacharya, Xiaowei Jin, Diane L. Rosin, Heidi E. Taylor
Publikováno v:
Drug Development Research. 39:243-252
The four human adenosine receptors (ARs), A 1 , A 2A , A 2B , and A 3 , have been stably expressed in mammalian cells. Radioligand binding properties were examined for all four subtypes, including, for the first time the A 2B AR. The A 1 AR-selective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b550079cbdaa9e6eea21c928f808c95
https://doi.org/10.1002/(sici)1098-2299(199611/12)39:3/4<243::aid-ddr3>3.0.co
https://doi.org/10.1002/(sici)1098-2299(199611/12)39:3/4<243::aid-ddr3>3.0.co
Publikováno v:
Biochemical Pharmacology. 51:545-555
An expression plasmid for mammalian cells (CLDN10B) has been modified to add nucleotides encoding hexahistidine and the FLAG peptide (H/F) to cDNAs. The new mammalian expression plasmid has been named pDoubleTrouble (pDT). The plasmid and a recombina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c9804c577bd5915eccef78abbf1a6bf
https://doi.org/10.1016/0006-2952(95)02235-x
https://doi.org/10.1016/0006-2952(95)02235-x
Autor:
Joel Linden, Kevin R. Lynch, D Holeton, Amy L. Tucker, Anna S. Robeva, M Bockner, Heidi E. Taylor
Publikováno v:
Journal of Biological Chemistry. 269:27900-27906
Species differences in ligand binding to A1 adenosine receptors were localized to the seventh transmembrane (TM7) region based on the binding of [8-3H]cyclopentyl-1, 3-dipropylxanthine and three other ligands to wild type and six bovine/canine inters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::653be257327c6813623310ae56122965
https://doi.org/10.1016/s0021-9258(18)46872-x
https://doi.org/10.1016/s0021-9258(18)46872-x
Publikováno v:
FEBS Letters. 297:107-111
A bovine brain adenosine A1 receptor cDNA encoding a 326 amino acid protein has been identified. This cDNA, which encodes a protein greater than 90% identical to analogous rat and dog receptors, was transiently expressed in COS-1 cells. Recombinant r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1439a59324021e176c39db33e733f7f2
https://doi.org/10.1016/0014-5793(92)80338-h
https://doi.org/10.1016/0014-5793(92)80338-h
Autor:
Patricia Rae, J. B. Singer, Francis J. Giles, Margaret Dugan, J. M. Meyer, Yi-Hsiang Hsu, Oliver G. Ottmann, Yaping Shou, Aaron Weitzman, Hagop M. Kantarjian, A. S. Robeva
Publikováno v:
Leukemia. 21(11)
Nilotinib is a novel BCR-ABL inhibitor with significantly improved potency and selectivity over imatinib. In Phase I and Phase II clinical studies of nilotinib in patients with a variety of leukemias, infrequent instances of reversible, benign elevat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0048bc37c5ea3ccdb7471e333afed864
https://pubmed.ncbi.nlm.nih.gov/17611564
https://pubmed.ncbi.nlm.nih.gov/17611564
Publikováno v:
Molecular pharmacology. 56(4)
Recombinant human A(2B) adenosine receptors (A(2B)ARs) and receptors extended on the amino terminus with hexahistidine and the FLAG epitope, DYKDDDDK (H/F-A(2B)) were stably overexpressed (to20,000 fmol/mg protein) in human embryonic kidney 293 cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7235b79cdec8105e361898e5584229be
https://pubmed.ncbi.nlm.nih.gov/10496952
https://pubmed.ncbi.nlm.nih.gov/10496952